X-LINKED RETINITIS PIGMENTOSA
Clinical trials for X-LINKED RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for X-LINKED RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy shows promise for rare eye disease
Disease control CompletedThis study tested a gene therapy called AAV5-RPGR for people with X-linked retinitis pigmentosa, a genetic eye disease that causes vision loss. The trial included 105 participants aged 3 and older. The main goal was to see if the treatment improved their ability to navigate a maz…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 09, 2026 08:20 UTC
-
Gene therapy watch: 5-Year safety check for inherited blindness treatment
Disease control CompletedThis study followed 42 people who had already received a gene therapy for X-linked retinitis pigmentosa, an inherited eye disease that causes vision loss. The main goal was to check the treatment's long-term safety over up to 5 years. Researchers also looked at changes in functio…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 07, 2026 18:39 UTC